(Q36344243)

13 August 2017

1 reference

title

Genetics of drug resistance. (English)

1 reference

13 August 2017

Sanjay M Sisodiya

1

1 reference

13 August 2017

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

46 Suppl 10

1 reference

13 August 2017

33-38

1 reference

New horizons in the development of antiepileptic drugs: the search for new targets.

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Anticonvulsant pharmacology of voltage-gated Na+ channels in hippocampal neurons of control and chronically epileptic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

A novel mechanism underlying drug resistance in chronic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Channelopathies as a genetic cause of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

A comprehensive review of genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Problems of reporting genetic associations with complex outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Genetic association studies in epilepsy: "the truth is out there".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Interleukin-1beta gene polymorphism and susceptibility to temporal lobe epilepsy with hippocampal sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Association Analysis of a Polymorphism of Interleukin 1β (IL‐1β) Gene with Temporal Lobe Epilepsy in a Chinese Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Lack of association between an interleukin 1 beta (IL-1beta) gene variation and refractory temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Surgical outcome in mesial temporal sclerosis correlates with prion protein gene variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Mechanisms of antiepileptic drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Role of multidrug transporters in pharmacoresistance to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Gefitinib (iressa) in oncogene-addictive cancers and therapy for common cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Pharmacogenetics goes genomic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Pharmacogenetics and drug development: the path to safer and more effective drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

The future of association studies: gene-based analysis and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

A functional polymorphism in the prodynorphin gene promotor is associated with temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00356.X

10.1111/J.1528-1167.2005.00356.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16359469